CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that the AUGMENTSM fertility treatment will be introduced to patients at IVI Valencia, a clinic within the IVI Group of 38 in vitro fertilization (IVF) clinics spanning nine countries in Europe, North America, South America and Asia. The AUGMENT treatment is not available in the United States.
Help employers find you! Check out all the jobs and post your resume.
